| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | alvocidib | CTRPv2 | pan-cancer | AAC | 0.18 | 0.0002 |
| mRNA | FTI-277 | GDSC1000 | pan-cancer | AAC | -0.13 | 0.0002 |
| mRNA | navitoclax:piperlongumine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0002 |
| mRNA | GSK690693 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0002 |
| mRNA | gossypol | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0002 |
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0003 |
| mRNA | tubastatin A | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0003 |
| mRNA | KW-2449 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0003 |
| mRNA | B02 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0003 |
| mRNA | ISOX | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0003 |